hair loss and tirzepatide Could your weight medication affect your hair? A new study suggests women using Mounjaro (tirzepatide) may have a higher risk of loss than those taking Wegovy or Ozempic (semaglutide). Researchers Tirzepatide Hair Loss: Timeline &

Semaglutide heralds significant advantages, and understanding its mechanism of action is crucial for optimal clinical utilization

Common challenges and how to overcome them Weight loss is an ongoing journey rather than something that changes quickly and remains permanent

However, 15% to 20% of ER+ tumors are intrinsically resistant to endocrine treatment while 30% to 40% of ER+ tumors develop endocrine resistance to this class of drugs throughout treatment [9, 10]

Meds & personalization based on clinical need

People with MEN2 or suspected MEN2 should absolutely avoid GLP-1 medications

We monitor your progress and make any adaptations to your treatment if needed